Non Small Cell Lung Cancer News and Research

RSS
Non-Small Cell Lung Cancers are a group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer.
Novel method uses just a drop of blood to monitor effect of lung cancer therapy

Novel method uses just a drop of blood to monitor effect of lung cancer therapy

Phase 2 results on tazemetostat EZH2 inhibitor to be presented at ESMO 2018

Phase 2 results on tazemetostat EZH2 inhibitor to be presented at ESMO 2018

Frequent surveillance imaging not associated with improved overall postoperative survival

Frequent surveillance imaging not associated with improved overall postoperative survival

Aggressive breast cancer hijacks normal protective physiological process to survive

Aggressive breast cancer hijacks normal protective physiological process to survive

Researchers design new combination therapy for reducing NSCLC cell growth

Researchers design new combination therapy for reducing NSCLC cell growth

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Non-small cell lung cancer patients survive longer when treated with durvalumab

Non-small cell lung cancer patients survive longer when treated with durvalumab

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

Survey: Physicians need more information to assess impact of NSCLC treatment sequencing

Survey: Physicians need more information to assess impact of NSCLC treatment sequencing

Brigatinib drug may offer first-line treatment option for ALK-positive NSCLC

Brigatinib drug may offer first-line treatment option for ALK-positive NSCLC

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

Genetic mutations may drive tumor formation by blurring growth signals

Genetic mutations may drive tumor formation by blurring growth signals

Forbius receives $18.75 million grant from CPRIT for Phase 2a development of AVID100

Forbius receives $18.75 million grant from CPRIT for Phase 2a development of AVID100

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

Immunovia's new blood-based testing platform accurately detects non-small cell lung cancer

Immunovia's new blood-based testing platform accurately detects non-small cell lung cancer

Inhibition of NOVA1 gene helps prevent growth of lung cancer tumors

Inhibition of NOVA1 gene helps prevent growth of lung cancer tumors

Blood-based test accurately identifies lung cancer patients who could benefit from immunotherapies

Blood-based test accurately identifies lung cancer patients who could benefit from immunotherapies